VIR

$0.00

(

+0.00%

)
Quote details

stock

Vir Biotechnology Inc

NASDAQ | VIR

5.69

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$783.27M

Market Cap

-

P/E Ratio

-3.36

EPS

$14.45

52 Week High

$4.15

52 Week Low

HEALTHCARE

Sector

VIR Chart

Recent Chart
Price Action

VIR Technicals

Tags:

VIR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$404M
Total Revenue $74M
Cost Of Revenue $479M
Costof Goods And Services Sold $479M
Operating Income -$587M
Selling General And Administrative $119M
Research And Development $506M
Operating Expenses $183M
Investment Income Net -
Net Interest Income $72M
Interest Income $72M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $15M
Income Before Tax -$523M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$522M
Comprehensive Income Net Of Tax -
Ebit -$523M
Ebitda -$509M
Net Income -$522M

Revenue & Profitability

Earnings Performance

VIR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.4B
Total Current Assets $1B
Cash And Cash Equivalents At Carrying Value $223M
Cash And Short Term Investments $223M
Inventory -
Current Net Receivables $5.1M
Total Non Current Assets $356M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $8.1M
Intangible Assets Excluding Goodwill $8.1M
Goodwill $17M
Investments -
Long Term Investments $190M
Short Term Investments $682M
Other Current Assets $137M
Other Non Current Assets -
Total Liabilities $248M
Total Current Liabilities $120M
Current Accounts Payable $5.1M
Deferred Revenue -
Current Debt -
Short Term Debt $7.8M
Total Non Current Liabilities $129M
Capital Lease Obligations $98M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $98M
Other Current Liabilities $94M
Other Non Current Liabilities $39M
Total Shareholder Equity $1.2B
Treasury Stock -
Retained Earnings -$760M
Common Stock $14K
Common Stock Shares Outstanding $136M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$446M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $15M
Capital Expenditures $7.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $499M
Cashflow From Financing $4.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$522M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$404M
Total Revenue $74M
Cost Of Revenue $479M
Costof Goods And Services Sold $479M
Operating Income -$587M
Selling General And Administrative $119M
Research And Development $506M
Operating Expenses $183M
Investment Income Net -
Net Interest Income $72M
Interest Income $72M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $15M
Income Before Tax -$523M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$522M
Comprehensive Income Net Of Tax -
Ebit -$523M
Ebitda -$509M
Net Income -$522M

VIR News

VIR Profile

Vir Biotechnology Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Vir Biotechnology, Inc. is a clinical-stage immunology company based in San Francisco, California, specializing in the development of innovative therapeutic solutions for serious infectious diseases. The company leverages its proprietary technologies and a robust pipeline that includes advanced monoclonal antibodies and immunotherapeutics to address significant unmet medical needs, particularly in viral infections like COVID-19 and influenza. Through strategic partnerships and collaborations, Vir enhances its research capabilities and positions itself as a pivotal entity in the biotechnology sector, committed to advancing global health outcomes.

LPTX
+368.57%
$2.05
VRAX
+65.51%
$0.65
NVDA
+0.85%
$181.46
VHAI
0.00%
$0.00
IXHL
+6.40%
$0.42
TWOH
0.00%
$0.00
PAVS
-23.95%
$0.04
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
ASST
-1.42%
$1.03
F
-1.51%
$12.96
ADAP
-15.14%
$0.05
PFE
-0.47%
$25.15
NIO
-2.89%
$5.03
SOND
-23.45%
$0.12
CLSK
-2.62%
$13.71
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ITUB
+2.64%
$7.89
GOOGL
+0.29%
$315.81
QCLS
+17.75%
$3.98
SRM
+53.27%
$10.30
GRAB
-0.18%
$5.26
PLTD
-1.83%
$6.96
ONDS
-3.28%
$7.80
BURU
-0.76%
$0.21
WLGS
-5.57%
$0.04
ASBP
+1.11%
$0.09
MTSR
-0.35%
$70.50
PCG
-3.28%
$15.32
CHR
-0.91%
$0.04
GPUS
+6.45%
$0.28
INHD
-8.22%
$0.13
AFMD
-34.94%
$0.18
BA
+10.14%
$205.38
IREN
+2.42%
$42.11
STLA
+2.81%
$10.95
VCIG
+0.95%
$1.06
IMRN
-2.29%
$1.70
VALE
+2.24%
$13.18
LUMN
+10.25%
$9.14
AMCR
-1.63%
$8.40
PMAX
+25.99%
$2.86
MRVL
+6.12%
$98.58
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
RR
+3.64%
$3.68
BMNU
+13.35%
$8.32
PLTZ
-3.85%
$6.99
XPEV
-7.91%
$19.66
AKTX
-14.10%
$0.34
BMNR
+7.01%
$34.15
BITF
-2.25%
$3.03
PLUG
+1.42%
$2.14
KDLY
-2.95%
$0.48
SAND
-6.04%
$12.12
BMY
-1.89%
$48.25
INTC
-1.05%
$43.01
CDE
-2.41%
$16.55
AUR
0.00%
$3.99
SHOT
-74.37%
$0.39
CMND
-21.68%
$0.10
VIVK
-6.01%
$0.10
ZAPP
-46.30%
$0.15
IONQ
-0.40%
$46.93
CAPR
+307.07%
$25.89
ARTL
-2.77%
$1.75
KXIN
+32.25%
$4.10
NFLX
-5.65%
$103.16
HIMS
-3.19%
$36.31
ALIT
-5.50%
$2.23
CPNG
+0.22%
$26.71
AEO
+15.38%
$24.03
SNDK
-2.29%
$205.35
IONZ
+0.51%
$4.48
USB
+0.54%
$49.68
SCHW
-0.66%
$92.07
CAG
-2.54%
$17.22
SONN
-59.35%
$1.26
YDKG
-27.37%
$1.30
BABA
-1.90%
$161.13
OWL
-0.79%
$14.91
PFSA
+9.92%
$0.17
YGMZ
-12.76%
$0.07
TXN
+4.22%
$175.26
FTRK
+14.28%
$0.44
AMZN
-1.28%
$231.40
PRMB
-0.48%
$16.33
AMAT
+4.15%
$265.33
NEM
-1.47%
$90.48
LYG
+2.37%
$5.17
TEVA
+0.59%
$26.88
APH
+1.63%
$141.49
AAPL
+0.47%
$287.54
MDLZ
-0.72%
$55.99
AAL
+1.89%
$14.51
GTLB
-15.81%
$36.50
CMCT
+8.59%
$3.79
BSX
-1.97%
$99.02
LPTX
+368.57%
$2.05
VRAX
+65.51%
$0.65
NVDA
+0.85%
$181.46
VHAI
0.00%
$0.00
IXHL
+6.40%
$0.42
TWOH
0.00%
$0.00
PAVS
-23.95%
$0.04
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
ASST
-1.42%
$1.03
F
-1.51%
$12.96
ADAP
-15.14%
$0.05
PFE
-0.47%
$25.15
NIO
-2.89%
$5.03
SOND
-23.45%
$0.12
CLSK
-2.62%
$13.71
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ITUB
+2.64%
$7.89
GOOGL
+0.29%
$315.81
QCLS
+17.75%
$3.98
SRM
+53.27%
$10.30
GRAB
-0.18%
$5.26
PLTD
-1.83%
$6.96
ONDS
-3.28%
$7.80
BURU
-0.76%
$0.21
WLGS
-5.57%
$0.04
ASBP
+1.11%
$0.09
MTSR
-0.35%
$70.50
PCG
-3.28%
$15.32
CHR
-0.91%
$0.04
GPUS
+6.45%
$0.28
INHD
-8.22%
$0.13
AFMD
-34.94%
$0.18
BA
+10.14%
$205.38
IREN
+2.42%
$42.11
STLA
+2.81%
$10.95
VCIG
+0.95%
$1.06
IMRN
-2.29%
$1.70
VALE
+2.24%
$13.18
LUMN
+10.25%
$9.14
AMCR
-1.63%
$8.40
PMAX
+25.99%
$2.86
MRVL
+6.12%
$98.58
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
RR
+3.64%
$3.68
BMNU
+13.35%
$8.32
PLTZ
-3.85%
$6.99
XPEV
-7.91%
$19.66
AKTX
-14.10%
$0.34
BMNR
+7.01%
$34.15
BITF
-2.25%
$3.03
PLUG
+1.42%
$2.14
KDLY
-2.95%
$0.48
SAND
-6.04%
$12.12
BMY
-1.89%
$48.25
INTC
-1.05%
$43.01
CDE
-2.41%
$16.55
AUR
0.00%
$3.99
SHOT
-74.37%
$0.39
CMND
-21.68%
$0.10
VIVK
-6.01%
$0.10
ZAPP
-46.30%
$0.15
IONQ
-0.40%
$46.93
CAPR
+307.07%
$25.89
ARTL
-2.77%
$1.75
KXIN
+32.25%
$4.10
NFLX
-5.65%
$103.16
HIMS
-3.19%
$36.31
ALIT
-5.50%
$2.23
CPNG
+0.22%
$26.71
AEO
+15.38%
$24.03
SNDK
-2.29%
$205.35
IONZ
+0.51%
$4.48
USB
+0.54%
$49.68
SCHW
-0.66%
$92.07
CAG
-2.54%
$17.22
SONN
-59.35%
$1.26
YDKG
-27.37%
$1.30
BABA
-1.90%
$161.13
OWL
-0.79%
$14.91
PFSA
+9.92%
$0.17
YGMZ
-12.76%
$0.07
TXN
+4.22%
$175.26
FTRK
+14.28%
$0.44
AMZN
-1.28%
$231.40
PRMB
-0.48%
$16.33
AMAT
+4.15%
$265.33
NEM
-1.47%
$90.48
LYG
+2.37%
$5.17
TEVA
+0.59%
$26.88
APH
+1.63%
$141.49
AAPL
+0.47%
$287.54
MDLZ
-0.72%
$55.99
AAL
+1.89%
$14.51
GTLB
-15.81%
$36.50
CMCT
+8.59%
$3.79
BSX
-1.97%
$99.02

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.